Literature DB >> 17051600

Importance of duodenogastric reflux in gastro-oesophageal reflux disease.

M Fein1, J Maroske, K-H Fuchs.   

Abstract

BACKGROUND: Bile in the oesophagus occurs frequently in patients with gastro-oesophageal reflux disease (GORD) and has been linked to Barrett's metaplasia and cancer. Although duodenogastric reflux is a prerequisite for bile in the oesophagus, little is known about its importance in GORD.
METHODS: Some 341 patients with GORD were assessed by simultaneous 24-h gastric and oesophageal bilirubin monitoring. Definitions of increased bilirubin exposure were based on the 95th percentiles in healthy volunteers. The relationship between gastric and oesophageal bilirubin exposure and the correlation with disease severity were analysed.
RESULTS: Of the 341 patients with GORD, 130 (38.1 per cent) had increased gastric and 173 (50.7 per cent) had increased oesophageal bilirubin exposure. Of the 173 patients with bile in the oesophagus, 89 (51.4 per cent) had normal and 84 (48.6 per cent) had increased gastric bilirubin exposure. Of these 84 patients, 75 (89 per cent) had oesophagitis or Barrett's oesophagus (P = 0.003). These effects were mainly related to differences in supine reflux.
CONCLUSION: Bile in the oesophagus originates from either normal or increased gastric bilirubin exposure. Patients with increased duodenogastric reflux are more likely to have oesophagitis or Barrett's oesophagus. These findings highlight the role of duodenogastric reflux as an additional factor in the pathogenesis of GORD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17051600     DOI: 10.1002/bjs.5486

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Impact of gastro-esophageal reflux on mucin mRNA expression in the esophageal mucosa.

Authors:  Aafke H C van Roon; George C Mayne; Bas P L Wijnhoven; David I Watson; Mary P Leong; Gabriëlle E Neijman; Michael Z Michael; Andrew R McKay; David Astill; Damian J Hussey
Journal:  J Gastrointest Surg       Date:  2008-05-02       Impact factor: 3.452

2.  Does impaired gallbladder function contribute to the development of Barrett's esophagus and esophageal adenocarcinoma?

Authors:  Ayman O Nassr; Syeda Nadia Shah Gilani; Mohammed Atie; Tariq Abdelhafiz; Val Connolly; Neil Hickey; Thomas Noel Walsh
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

3.  EAES recommendations for the management of gastroesophageal reflux disease.

Authors:  Karl Hermann Fuchs; Benjamin Babic; Wolfram Breithaupt; Bernard Dallemagne; Abe Fingerhut; Edgar Furnee; Frank Granderath; Peter Horvath; Peter Kardos; Rudolph Pointner; Edoardo Savarino; Maud Van Herwaarden-Lindeboom; Giovanni Zaninotto
Journal:  Surg Endosc       Date:  2014-05-02       Impact factor: 4.584

4.  Pathophysiology of gastroesophageal reflux disease-which factors are important?

Authors:  Karl-Hermann Fuchs; Arielle M Lee; Wolfram Breithaupt; Gabor Varga; Benjamin Babic; Santiago Horgan
Journal:  Transl Gastroenterol Hepatol       Date:  2021-10-25

5.  Laparoscopic conversion of omega loop gastric bypass to Roux-en-Y gastric bypass for Barrett's esophagus: case report.

Authors:  U G Lange; Y Moulla; M Mehdorn; J Tuennemann; A Zabel-Langhennig; A Ouaid; A Dietrich
Journal:  BMC Surg       Date:  2022-07-14       Impact factor: 2.030

6.  Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned.

Authors:  Vic Velanovich
Journal:  Surg Endosc       Date:  2009-03-05       Impact factor: 4.584

7.  Should peri-gastrectomy gastric acidity be our focus among gastric cancer patients?

Authors:  Lei Huang; A-Man Xu; Tuan-Jie Li; Wen-Xiu Han; Jing Xu
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

8.  Effect of cholecystectomy on gastric and esophageal bile reflux in patients with upper gastrointestinal symptoms.

Authors:  Martin Fein; Marco Bueter; Marco Sailer; Karl-Herrmann Fuchs
Journal:  Dig Dis Sci       Date:  2007-10-16       Impact factor: 3.199

9.  Mutational signature distribution varies with DNA replication timing and strand asymmetry.

Authors:  Marketa Tomkova; Jakub Tomek; Skirmantas Kriaucionis; Benjamin Schuster-Böckler
Journal:  Genome Biol       Date:  2018-09-10       Impact factor: 13.583

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.